Cellular Biomedicine Group, Inc. EBITDA 2010-2020 | CBMG
Cellular Biomedicine Group, Inc. ebitda from 2010 to 2020. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Cellular Biomedicine Group, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2019 | $-45 |
| 2018 | $-33 |
| 2017 | $-25 |
| 2016 | $-26 |
| 2015 | $-19 |
| 2014 | $-8 |
| 2013 | $-6 |
| 2012 | $-7 |
| 2011 | $-1 |
| 2010 | $0 |
| 2009 | $-1 |
| Cellular Biomedicine Group, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2020-09-30 | $-16 |
| 2020-06-30 | $-12 |
| 2020-03-31 | $-10 |
| 2019-12-31 | $-11 |
| 2019-09-30 | $-15 |
| 2019-06-30 | $-11 |
| 2019-03-31 | $-8 |
| 2018-12-31 | $-9 |
| 2018-09-30 | $-9 |
| 2018-06-30 | $-8 |
| 2018-03-31 | $-7 |
| 2017-12-31 | $-7 |
| 2017-09-30 | $-6 |
| 2017-06-30 | $-6 |
| 2017-03-31 | $-6 |
| 2016-12-31 | $-6 |
| 2016-09-30 | $-10 |
| 2016-06-30 | $-6 |
| 2016-03-31 | $-5 |
| 2015-12-31 | $-5 |
| 2015-09-30 | $-5 |
| 2015-06-30 | $-5 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $1 |
| 2014-03-31 | $-2 |
| 2013-12-31 | $2 |
| 2013-09-30 | $-2 |
| 2013-06-30 | $-2 |
| 2013-03-31 | $-5 |
| 2012-12-31 | $-4 |
| 2012-09-30 | $-1 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-1 |
| 2011-12-31 | $-0 |
| 2011-09-30 | $-0 |
| 2011-06-30 | $-0 |
| 2011-03-31 | $-0 |
| 2010-12-31 | |
| 2010-09-30 | $-0 |
| 2010-06-30 | $-0 |
| 2010-03-31 | |
| 2009-12-31 | |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | |
